Louisiana woman files first Ozempic and Mounjaro lawsuit over side effects of weight loss, diabetes drugs

Last Fall, a lawsuit was filed by a woman from Louisiana who was diagnosed with severe gastrointestinal issues after using the weight loss and diabetes medications Ozempic and Mounjaro.

Both of these drugs, Ozempic (semaglutide) and Mounjaro (tirzepatide), belong to a class of medications called GLP-1 receptor agonists. Although initially developed to treat type 2 diabetes, these drugs have been increasingly prescribed for weight loss and weight control in recent years.

Lawsuit Alleges Ozempic, Mounjaro Linked to Stomach Problems

Jaclyn Bjorklund, the plaintiff, claims that she was prescribed Ozempic by her doctor to manage her type 2 diabetes symptoms. Subsequently, in July 2023, she started taking Mounjaro.

After several months of using these medications, Bjorklund alleges that she experienced severe gastrointestinal problems, including stomach pain and vomiting. She states that her condition became so severe that she had to be hospitalized and required additional medications to alleviate her gastrointestinal issues.

The Ozempic and Mounjaro lawsuit filed by Bjorklund asserts that the manufacturers of these drugs, Novo Nordisk and Eli Lilly, failed to adequately warn patients about the potential risk of gastrointestinal problems that the medications could cause.

The lawsuit also alleges that these drugmakers were aware of the connection between GLP-1 receptor agonists like Ozempic and Mounjaro and the increased likelihood of gastroparesis and other gastrointestinal conditions, yet they neglected to disclose this information to both doctors and patients.

Reports Link Diabetes and Weight Loss Drugs to Gastroparesis, Other Side Effects

As the use of Ozempic and similar medications for weight loss and weight control has become more widespread, medical professionals and patients have started to raise concerns about the potential gastrointestinal side effects linked to these drugs.

Gastroparesis, a chronic condition characterized by weakened nerves and muscles in the stomach, is one of the serious complications that can arise from the use of diabetes drugs such as Ozempic. Patients who have been prescribed medications like Ozempic, Mounjaro, Rybelsus, Saxenda, Trulicity, or Wegovy for diabetes or weight loss may also be at risk of developing other gastrointestinal issues, including nausea and diarrhea.

Furthermore, the use of these medications has been linked to various gastrointestinal conditions such as bowel obstructions, ileus, intestinal blockages, and even stomach paralysis, commonly referred to as “frozen stomach.”

Contact Us to Start Your Claim Today

If you or a loved one used one of the diabetes or weight control drugs listed above have been diagnosed with gastroparesis or other gastrointestinal conditions, it is crucial to take legal action. You may be eligible to file a Ozempic lawsuit and seek compensation.

To initiate the process of filing your claim, we urge you to contact the experienced lawyers at Hissey Mulderig & Friend. You can reach our office toll-free at 1-866-806-8117 or fill out our free claims submission form located on the right side of this page. Act now to protect your rights and explore your legal options.

About the Author: Hissey, Mulderig & Friend